Vanda Pharmaceuticals reported $32.46M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Akebia Therapeutics AKBA:US $ 46.36M 4.71M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Anika Therapeutics ANIK:US $ 17.5M 489K
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
AstraZeneca AZN:LN 2.99B 412M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Clovis Oncology CLVS:US $ 32.2M 722K
Eli Lilly And LLY:US $ 1.58B 107.8M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Insmed INSM:US $ 60.28M 3.1M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Johnson & Johnson JNJ:US $ 6B 73M
Lexicon Pharmaceuticals LXRX:US 7.3M 633K
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Merk MRK:US $ 2.27B 9M
Minerva Neurosciences NERV:US $ 3M 437.6K
Moderna Inc MRNA:US 168M 47M
Novartis NVS:US 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Takeda 4502:JP 212.01B 7.83B
Teva Pharmaceutical TEVA:IT 864M 32M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vanda Pharmaceuticals VNDA:US $ 32.46M 4.11M
Veracyte VCYT:US $ 59.54M 39.63M